Consistent with previous findings, UCP2 expression was shown to be significantly greater in GBM tissue than non-tumor tissue in an analysis of the TCGA GBM database containing 10 non-tumor samples and 528 Glioblastoma samples (p<0.05, Figure 1B). The gene discussed is UCP2; the disease is glioblastoma.